The hematopoietic growth factors, such as interleukin (IL)-1β, IL-6, IL-8, and tumor necrosis factor (TNF), play a central role in DS through promoting leukocyte activation and the binding of APL cells to endothelium [39,41]. Here, TNF is linked to Dravet syndrome.